RESEARCH TRIANGLE PARK – Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback